BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36978104)

  • 1. Stem cell sources and characterization in the development of cell-based products for treating retinal disease: An NEI Town Hall report.
    Fortress AM; Miyagishima KJ; Reed AA; Temple S; Clegg DO; Tucker BA; Blenkinsop TA; Harb G; Greenwell TN; Ludwig TE; Bharti K
    Stem Cell Res Ther; 2023 Mar; 14(1):53. PubMed ID: 36978104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise Review: Making Stem Cells Retinal: Methods for Deriving Retinal Pigment Epithelium and Implications for Patients With Ocular Disease.
    Leach LL; Clegg DO
    Stem Cells; 2015 Aug; 33(8):2363-73. PubMed ID: 25809736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoring Vision Using Stem Cells and Transplantation.
    Cuevas E; Parmar P; Sowden JC
    Adv Exp Med Biol; 2019; 1185():563-567. PubMed ID: 31884671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem Cell-Based RPE Therapy for Retinal Diseases: Engineering 3D Tissues Amenable for Regenerative Medicine.
    Ben M'Barek K; Habeler W; Monville C
    Adv Exp Med Biol; 2018; 1074():625-632. PubMed ID: 29721996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent Stem Cells in Clinical Cell Transplantation: Focusing on Induced Pluripotent Stem Cell-Derived RPE Cell Therapy in Age-Related Macular Degeneration.
    Yang YP; Hsiao YJ; Chang KJ; Foustine S; Ko YL; Tsai YC; Tai HY; Ko YC; Chiou SH; Lin TC; Chen SJ; Chien Y; Hwang DK
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human-induced pluripotent stem cells-derived retinal pigmented epithelium, a new horizon for cells-based therapies for age-related macular degeneration.
    Dehghan S; Mirshahi R; Shoae-Hassani A; Naseripour M
    Stem Cell Res Ther; 2022 May; 13(1):217. PubMed ID: 35619143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Based Therapies for Age-Related Macular Degeneration.
    Khateb S; Jha S; Bharti K; Banin E
    Adv Exp Med Biol; 2021; 1256():265-293. PubMed ID: 33848006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoid Processing in Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cultures.
    Fields MA; Bowrey HE; Gong J; Ablonczy Z; Del Priore LV
    Prog Mol Biol Transl Sci; 2015; 134():477-90. PubMed ID: 26310172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Therapy and Stem Cell Transplantation in Retinal Disease: The New Frontier.
    MacLaren RE; Bennett J; Schwartz SD
    Ophthalmology; 2016 Oct; 123(10S):S98-S106. PubMed ID: 27664291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing cellular therapies for retinal degenerative diseases.
    Bharti K; Rao M; Hull SC; Stroncek D; Brooks BP; Feigal E; van Meurs JC; Huang CA; Miller SS
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1191-202. PubMed ID: 24573369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient and robust induction of retinal pigment epithelium cells by tankyrase inhibition regardless of the differentiation propensity of human induced pluripotent stem cells.
    Ito A; Ye K; Onda M; Morimoto N; Osakada F
    Biochem Biophys Res Commun; 2021 May; 552():66-72. PubMed ID: 33743349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabricating retinal pigment epithelial cell sheets derived from human induced pluripotent stem cells in an automated closed culture system for regenerative medicine.
    Matsumoto E; Koide N; Hanzawa H; Kiyama M; Ohta M; Kuwabara J; Takeda S; Takahashi M
    PLoS One; 2019; 14(3):e0212369. PubMed ID: 30865653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stemming retinal regeneration with pluripotent stem cells.
    Jin ZB; Gao ML; Deng WL; Wu KC; Sugita S; Mandai M; Takahashi M
    Prog Retin Eye Res; 2019 Mar; 69():38-56. PubMed ID: 30419340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing a Stem Cell Therapy for Age-Related Macular Degeneration.
    O'Neill HC; Limnios IJ; Barnett NL
    Curr Stem Cell Res Ther; 2020; 15(2):89-97. PubMed ID: 31854278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat.
    Carr AJ; Vugler AA; Hikita ST; Lawrence JM; Gias C; Chen LL; Buchholz DE; Ahmado A; Semo M; Smart MJ; Hasan S; da Cruz L; Johnson LV; Clegg DO; Coffey PJ
    PLoS One; 2009 Dec; 4(12):e8152. PubMed ID: 19997644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem Cell-based Treatment Strategies for Degenerative Diseases of the Retina.
    Nair DSR; Thomas BB
    Curr Stem Cell Res Ther; 2022; 17(3):214-225. PubMed ID: 34348629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retinal Cell Therapy Using iPS Cells].
    Takahashi M
    Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):210-24; discussion 225. PubMed ID: 27164758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Looking into the future: Using induced pluripotent stem cells to build two and three dimensional ocular tissue for cell therapy and disease modeling.
    Song MJ; Bharti K
    Brain Res; 2016 May; 1638(Pt A):2-14. PubMed ID: 26706569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification of small molecules that stimulate retinal pigment epithelial cells: potential novel therapeutic options for treating retinopathies.
    Artero-Castro A; Popelka S; Jendelova P; Motlik J; Ardan T; Rodriguez Jimenez FJ; Erceg S
    Expert Opin Drug Discov; 2019 Feb; 14(2):169-177. PubMed ID: 30616395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium.
    Ouyang H; Goldberg JL; Chen S; Li W; Xu GT; Li W; Zhang K; Nussenblatt RB; Liu Y; Xie T; Chan CC; Zack DJ
    Int J Mol Sci; 2016 Mar; 17(3):415. PubMed ID: 27102165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.